Higher levels of co-expression of at least two of those molecules were also observed in CD8 T cells of HPV+ HNSCC compared to HPV- HNSCC, which suggests T cell anti-tumor immunity and contribution to long term remission (52). The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.